Click here to get full coverage on Is It Smart To Buy Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend? - simplywall.st

Is It Smart To Buy Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend?  simplywall.st

Is It Smart To Buy Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend? - simplywall.st

Click here to get full coverage on Enterprise value to EBIT forward of Bliss GVS Pharma Limited – NSE:BLISSGVS - TradingView

Enterprise value to EBIT forward of Bliss GVS Pharma Limited – NSE:BLISSGVS  TradingView

Enterprise value to EBIT forward of Bliss GVS Pharma Limited – NSE:BLISSGVS - TradingView

Click here to get full coverage on Rahul Adakmol Appointed Chief Executive Officer at Bliss GVS Pharma Ltd. - hrtoday.in

Rahul Adakmol Appointed Chief Executive Officer at Bliss GVS Pharma Ltd.  hrtoday.in

Rahul Adakmol Appointed Chief Executive Officer at Bliss GVS Pharma Ltd. - hrtoday.in

Click here to get full coverage on Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore - Moneycontrol.com

Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore  Moneycontrol.com

Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore - Moneycontrol.com

Click here to get full coverage on Bliss GVS Pharma's (NSE:BLISSGVS) 37% CAGR outpaced the company's earnings growth over the same three-year period - webull.com.my

Bliss GVS Pharma's (NSE:BLISSGVS) 37% CAGR outpaced the company's earnings growth over the same three-year period  webull.com.my

Bliss GVS Pharma's (NSE:BLISSGVS) 37% CAGR outpaced the company's earnings growth over the same three-year period - webull.com.my

Click here to get full coverage on Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions - CNBC TV18

Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions  CNBC TV18

Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions - CNBC TV18

Click here to get full coverage on Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma - Indian Pharma Post

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma  Indian Pharma Post

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma - Indian Pharma Post

Click here to get full coverage on Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr - The Economic Times

Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr  The Economic Times

Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr - The Economic Times

Click here to get full coverage on HOT STOCKS: Anupam Rasayan Surges on Bliss GVS Acquisition, PSPPROJECT and JAMNAAUTO Gain, GREENLAM and RAIN Decline, NATIONALUM Near Key SMA Breakout - MarketSmith India

HOT STOCKS: Anupam Rasayan Surges on Bliss GVS Acquisition, PSPPROJECT and JAMNAAUTO Gain, GREENLAM and RAIN Decline, NATIONALUM Near Key SMA Breakout  MarketSmith India

HOT STOCKS: Anupam Rasayan Surges on Bliss GVS Acquisition, PSPPROJECT and JAMNAAUTO Gain, GREENLAM and RAIN Decline, NATIONALUM Near Key SMA Breakout - MarketSmith India

Click here to get full coverage on Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost - India Infoline

Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost  India Infoline

Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost - India Infoline

Click here to get full coverage on Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today? - simplywall.st

Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today?  simplywall.st

Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today? - simplywall.st

Click here to get full coverage on Bliss GVS Pharma shares hits 52-week high on inspection closure report from WHO - Moneycontrol.com

Bliss GVS Pharma shares hits 52-week high on inspection closure report from WHO  Moneycontrol.com

Bliss GVS Pharma shares hits 52-week high on inspection closure report from WHO - Moneycontrol.com

Click here to get full coverage on Be Sure To Check Out Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend - simplywall.st

Be Sure To Check Out Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend  simplywall.st

Be Sure To Check Out Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend - simplywall.st

Click here to get full coverage on Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization - TradingView

Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization  TradingView

Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization - TradingView

Click here to get full coverage on BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared - TradingView

BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared  TradingView

BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared - TradingView

Click here to get full coverage on Bliss GVS Pharma Limited (NSE:BLISSGVS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

Bliss GVS Pharma Limited (NSE:BLISSGVS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?  simplywall.st

Bliss GVS Pharma Limited (NSE:BLISSGVS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

Click here to get full coverage on Anupam Rasayan To Acquire Up to 43% Stake In Bliss GVS Pharma For Around Rs 1,369 Crore - NDTV Profit

Anupam Rasayan To Acquire Up to 43% Stake In Bliss GVS Pharma For Around Rs 1,369 Crore  NDTV Profit

Anupam Rasayan To Acquire Up to 43% Stake In Bliss GVS Pharma For Around Rs 1,369 Crore - NDTV Profit

Click here to get full coverage on Five Stocks To Buy: Welspun Corp, J&K Bank, Bliss GVS, FACT, And Newgen Software - NDTV Profit

Five Stocks To Buy: Welspun Corp, J&K Bank, Bliss GVS, FACT, And Newgen Software  NDTV Profit

Five Stocks To Buy: Welspun Corp, J&K Bank, Bliss GVS, FACT, And Newgen Software - NDTV Profit

Click here to get full coverage on Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake - CNBC TV18

Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake  CNBC TV18

Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake - CNBC TV18

Click here to get full coverage on Bliss GVS Pharma Secures WHO GMP Compliance for Palghar Facility Boosting Access to 60+ International Markets - Sahi

Bliss GVS Pharma Secures WHO GMP Compliance for Palghar Facility Boosting Access to 60+ International Markets  Sahi

Bliss GVS Pharma Secures WHO GMP Compliance for Palghar Facility Boosting Access to 60+ International Markets - Sahi

Click here to get full coverage on Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma - BusinessLine

Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma  BusinessLine

Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma - BusinessLine

Click here to get full coverage on Anupam Rasayan sees strong pharma growth opportunity through Bliss GVS deal - CNBC TV18

Anupam Rasayan sees strong pharma growth opportunity through Bliss GVS deal  CNBC TV18

Anupam Rasayan sees strong pharma growth opportunity through Bliss GVS deal - CNBC TV18

Click here to get full coverage on Anupam Rasayan to acquire up to 74.20% in Bliss GVS for ₹2,198 crore - scanx.trade

Anupam Rasayan to acquire up to 74.20% in Bliss GVS for ₹2,198 crore  scanx.trade

Anupam Rasayan to acquire up to 74.20% in Bliss GVS for ₹2,198 crore - scanx.trade

Click here to get full coverage on Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition - CNBC TV18

Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition  CNBC TV18

Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition - CNBC TV18

Click here to get full coverage on Bliss GVS Standalone December 2025 Net Sales at Rs 164.68 crore, down 8.3% Y-o-Y - Moneycontrol.com

Bliss GVS Standalone December 2025 Net Sales at Rs 164.68 crore, down 8.3% Y-o-Y  Moneycontrol.com

Bliss GVS Standalone December 2025 Net Sales at Rs 164.68 crore, down 8.3% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Here's Why Shareholders Will Not Be Complaining About Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Pay Packet - simplywall.st

Here's Why Shareholders Will Not Be Complaining About Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Pay Packet  simplywall.st

Here's Why Shareholders Will Not Be Complaining About Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Pay Packet - simplywall.st

Click here to get full coverage on Bliss GVS Pharma Publishes Q3FY26 Results in Newspapers Under SEBI Regulation 47 - scanx.trade

Bliss GVS Pharma Publishes Q3FY26 Results in Newspapers Under SEBI Regulation 47  scanx.trade

Bliss GVS Pharma Publishes Q3FY26 Results in Newspapers Under SEBI Regulation 47 - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Clarifies Media Reports on Potential Anupam Rasayan Stake Acquisition - scanx.trade

Bliss GVS Pharma Clarifies Media Reports on Potential Anupam Rasayan Stake Acquisition  scanx.trade

Bliss GVS Pharma Clarifies Media Reports on Potential Anupam Rasayan Stake Acquisition - scanx.trade

Click here to get full coverage on Bliss GVS Pharma - Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any? - The Economic Times

Bliss GVS Pharma - Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any?  The Economic Times

Bliss GVS Pharma - Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any? - The Economic Times

Click here to get full coverage on Bliss GVS Pharma Ltd. Share Price Today - Bliss GVS Pharma Ltd. Stock Price Live NSE/BSE - CNBC TV18

Bliss GVS Pharma Ltd. Share Price Today - Bliss GVS Pharma Ltd. Stock Price Live NSE/BSE  CNBC TV18

Bliss GVS Pharma Ltd. Share Price Today - Bliss GVS Pharma Ltd. Stock Price Live NSE/BSE - CNBC TV18

Click here to get full coverage on Stocks to Watch, May 25: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, CBI - BusinessLine

Stocks to Watch, May 25: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, CBI  BusinessLine

Stocks to Watch, May 25: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, CBI - BusinessLine

Click here to get full coverage on ​Bliss GVS Pharma - Multibaggers: 15 stocks with 25%+ sales and profit growth in Q4 March 2026 - The Economic Times

​Bliss GVS Pharma - Multibaggers: 15 stocks with 25%+ sales and profit growth in Q4 March 2026  The Economic Times

​Bliss GVS Pharma - Multibaggers: 15 stocks with 25%+ sales and profit growth in Q4 March 2026 - The Economic Times

Click here to get full coverage on Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter - Business Standard

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter  Business Standard

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter - Business Standard

Click here to get full coverage on Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure... - Moneycontrol.com

Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure...  Moneycontrol.com

Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure... - Moneycontrol.com

Click here to get full coverage on Return all Bliss GVS Pharma drugs-FDA - Modern Ghana

Return all Bliss GVS Pharma drugs-FDA  Modern Ghana

Return all Bliss GVS Pharma drugs-FDA - Modern Ghana

Click here to get full coverage on Bliss GVS Pharma Board Meeting Scheduled on May 12, 2026 to Approve Q4 FY26 Results and Final Dividend - scanx.trade

Bliss GVS Pharma Board Meeting Scheduled on May 12, 2026 to Approve Q4 FY26 Results and Final Dividend  scanx.trade

Bliss GVS Pharma Board Meeting Scheduled on May 12, 2026 to Approve Q4 FY26 Results and Final Dividend - scanx.trade

Click here to get full coverage on Anupam Rasayan offers ₹299 per share for Bliss GVS - scanx.trade

Anupam Rasayan offers ₹299 per share for Bliss GVS  scanx.trade

Anupam Rasayan offers ₹299 per share for Bliss GVS - scanx.trade

Click here to get full coverage on Bliss GVS Pharma fixes record date for FY26 dividend - scanx.trade

Bliss GVS Pharma fixes record date for FY26 dividend  scanx.trade

Bliss GVS Pharma fixes record date for FY26 dividend - scanx.trade

Click here to get full coverage on Anupam Rasayan enters pharma space with Bliss GVS deal; stock slips 4% from day’s high - Fortune India

Anupam Rasayan enters pharma space with Bliss GVS deal; stock slips 4% from day’s high  Fortune India

Anupam Rasayan enters pharma space with Bliss GVS deal; stock slips 4% from day’s high - Fortune India

Click here to get full coverage on Bliss GVS Pharma Hits 52-Week High After WHO GMP Nod - Equitypandit

Bliss GVS Pharma Hits 52-Week High After WHO GMP Nod  Equitypandit

Bliss GVS Pharma Hits 52-Week High After WHO GMP Nod - Equitypandit

Click here to get full coverage on Bliss GVS Pharma FY26 Net Profit Rises to ₹9,687.44 Lakh - scanx.trade

Bliss GVS Pharma FY26 Net Profit Rises to ₹9,687.44 Lakh  scanx.trade

Bliss GVS Pharma FY26 Net Profit Rises to ₹9,687.44 Lakh - scanx.trade

Click here to get full coverage on Bliss GVS Pharma's Managing Director Gagan Harsh Sharma Steps Down - scanx.trade

Bliss GVS Pharma's Managing Director Gagan Harsh Sharma Steps Down  scanx.trade

Bliss GVS Pharma's Managing Director Gagan Harsh Sharma Steps Down - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Expands Share Capital Through Employee Stock Option Allotment - scanx.trade

Bliss GVS Pharma Expands Share Capital Through Employee Stock Option Allotment  scanx.trade

Bliss GVS Pharma Expands Share Capital Through Employee Stock Option Allotment - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Shareholders Approve Appointment of Two Independent Directors via Postal Ballot - scanx.trade

Bliss GVS Pharma Shareholders Approve Appointment of Two Independent Directors via Postal Ballot  scanx.trade

Bliss GVS Pharma Shareholders Approve Appointment of Two Independent Directors via Postal Ballot - scanx.trade

Click here to get full coverage on Anupam Rasayan files draft offer for Bliss GVS - scanx.trade

Anupam Rasayan files draft offer for Bliss GVS  scanx.trade

Anupam Rasayan files draft offer for Bliss GVS - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Establishes Wholly Owned Subsidiary in Democratic Republic of Congo - scanx.trade

Bliss GVS Pharma Establishes Wholly Owned Subsidiary in Democratic Republic of Congo  scanx.trade

Bliss GVS Pharma Establishes Wholly Owned Subsidiary in Democratic Republic of Congo - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Grants 5.53 Lakh Stock Options to Employees at 72% Discount - scanx.trade

Bliss GVS Pharma Grants 5.53 Lakh Stock Options to Employees at 72% Discount  scanx.trade

Bliss GVS Pharma Grants 5.53 Lakh Stock Options to Employees at 72% Discount - scanx.trade

Click here to get full coverage on Anupam Rasayan launches ₹829 cr open offer for Bliss GVS - scanx.trade

Anupam Rasayan launches ₹829 cr open offer for Bliss GVS  scanx.trade

Anupam Rasayan launches ₹829 cr open offer for Bliss GVS - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Extends Special Window for Physical Share Transfer Re-lodgement Until February 2027 - scanx.trade

Bliss GVS Pharma Extends Special Window for Physical Share Transfer Re-lodgement Until February 2027  scanx.trade

Bliss GVS Pharma Extends Special Window for Physical Share Transfer Re-lodgement Until February 2027 - scanx.trade

Click here to get full coverage on Bliss GVS Pharma Board Approves CEO S.N. Kamath's Appointment as Managing Director - scanx.trade

Bliss GVS Pharma Board Approves CEO S.N. Kamath's Appointment as Managing Director  scanx.trade

Bliss GVS Pharma Board Approves CEO S.N. Kamath's Appointment as Managing Director - scanx.trade

Click here to get full coverage on Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director - CNBC TV18

Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director  CNBC TV18

Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director - CNBC TV18

Click here to get full coverage on Three Smallcap Stocks To Buy: Kakatiya Cement, Bliss GVS, And Arvind — Check Target Price - NDTV Profit

Three Smallcap Stocks To Buy: Kakatiya Cement, Bliss GVS, And Arvind — Check Target Price  NDTV Profit

Three Smallcap Stocks To Buy: Kakatiya Cement, Bliss GVS, And Arvind — Check Target Price - NDTV Profit

Click here to get full coverage on Internal restructuring of foreign subsidiaries at Bliss GVS Pharma - Indian Pharma Post

Internal restructuring of foreign subsidiaries at Bliss GVS Pharma  Indian Pharma Post

Internal restructuring of foreign subsidiaries at Bliss GVS Pharma - Indian Pharma Post

Click here to get full coverage on US FDA issues Form 483 with three observations for Bliss GVS Pharma’s Palghar unit - CNBC TV18

US FDA issues Form 483 with three observations for Bliss GVS Pharma’s Palghar unit  CNBC TV18

US FDA issues Form 483 with three observations for Bliss GVS Pharma’s Palghar unit - CNBC TV18

Click here to get full coverage on Bliss GVS Pharma donates anti-malaria drugs worth GHS100,000 to St. Patrick’s Hospital - The Business & Financial Times

Bliss GVS Pharma donates anti-malaria drugs worth GHS100,000 to St. Patrick’s Hospital  The Business & Financial Times

Bliss GVS Pharma donates anti-malaria drugs worth GHS100,000 to St. Patrick’s Hospital - The Business & Financial Times

Click here to get full coverage on Bliss GVS Pharma Ghana donates medicines again to Cape Coast Teaching Hospital - The Business & Financial Times

Bliss GVS Pharma Ghana donates medicines again to Cape Coast Teaching Hospital  The Business & Financial Times

Bliss GVS Pharma Ghana donates medicines again to Cape Coast Teaching Hospital - The Business & Financial Times

Click here to get full coverage on Technical Analysis of Bliss GVS Pharma Limited (NSE:BLISSGVS) - TradingView

Technical Analysis of Bliss GVS Pharma Limited (NSE:BLISSGVS)  TradingView

Technical Analysis of Bliss GVS Pharma Limited (NSE:BLISSGVS) - TradingView

Click here to get full coverage on Bliss GVS Pharma presents GH₵150,000 anti-malaria drugs to hospitals - Ghanaian Times

Bliss GVS Pharma presents GH₵150,000 anti-malaria drugs to hospitals  Ghanaian Times

Bliss GVS Pharma presents GH₵150,000 anti-malaria drugs to hospitals - Ghanaian Times

Click here to get full coverage on Bliss GVS Pharma donates antimalarial drugs to 3 regional hospitals - Graphic Online

Bliss GVS Pharma donates antimalarial drugs to 3 regional hospitals  Graphic Online

Bliss GVS Pharma donates antimalarial drugs to 3 regional hospitals - Graphic Online

Click here to get full coverage on Bliss GVS Pharma donates medicines to Tamale West Hospital - The Business & Financial Times

Bliss GVS Pharma donates medicines to Tamale West Hospital  The Business & Financial Times

Bliss GVS Pharma donates medicines to Tamale West Hospital - The Business & Financial Times

Click here to get full coverage on KCH receives a boost as Bliss GVS donates K10m worth of medical and pharmaceutical supplies - Nyasa Times

KCH receives a boost as Bliss GVS donates K10m worth of medical and pharmaceutical supplies  Nyasa Times

KCH receives a boost as Bliss GVS donates K10m worth of medical and pharmaceutical supplies - Nyasa Times

Click here to get full coverage on Bliss GVS Pharma buys stake in Eco-rich Cosmetic India - Express Pharma

Bliss GVS Pharma buys stake in Eco-rich Cosmetic India  Express Pharma

Bliss GVS Pharma buys stake in Eco-rich Cosmetic India - Express Pharma

Click here to get full coverage on Bliss GVS Pharma shares close at upper circuit, hit record high today; here's why - Business Today

Bliss GVS Pharma shares close at upper circuit, hit record high today; here's why  Business Today

Bliss GVS Pharma shares close at upper circuit, hit record high today; here's why - Business Today

Click here to get full coverage on Bliss GVS Pharma Skyrockets with 129% Profit Surge; Board Approves 100% Dividend Pay-out - Trade Brains

Bliss GVS Pharma Skyrockets with 129% Profit Surge; Board Approves 100% Dividend Pay-out  Trade Brains

Bliss GVS Pharma Skyrockets with 129% Profit Surge; Board Approves 100% Dividend Pay-out - Trade Brains

Click here to get full coverage on Bliss GVS Pharma Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend - MarketsMojo

Bliss GVS Pharma Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend  MarketsMojo

Bliss GVS Pharma Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend - MarketsMojo

Click here to get full coverage on Bliss GVS Pharma Ltd is Rated Hold - MarketsMojo

Bliss GVS Pharma Ltd is Rated Hold  MarketsMojo

Bliss GVS Pharma Ltd is Rated Hold - MarketsMojo

Click here to get full coverage on Anupam Rasayan India Ltd Strong FY26 Performance and Strategic Acquisition of Bliss GVS Pharma - InvestyWise

Anupam Rasayan India Ltd Strong FY26 Performance and Strategic Acquisition of Bliss GVS Pharma  InvestyWise

BLISSGVS

Price Chart

Key Statistics

Technicals

About BLISSGVS

Latest News

Is It Smart To Buy Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend? - simplywall.st

Enterprise value to EBIT forward of Bliss GVS Pharma Limited – NSE:BLISSGVS - TradingView

Rahul Adakmol Appointed Chief Executive Officer at Bliss GVS Pharma Ltd. - hrtoday.in

Advanced Charts

Top Gainers

Top Losers